ConductScience.org, home

Paper3315280

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.

Powis G and 3 others. Cancer Chemother Pharmacol, 1987. Cited by 103 papers, by iCite.

Cite this record

ConductScience Library. Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients. Papers, record 3315280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3315280

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article
PubMed
Citations, by iCite
103
iCite
Relative citation ratio, by iCite
3.57
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Powis GG
2Reece PP
3Ahmann DLD L
4Ingle JNJ N

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Body WeightMajor topic
Breast NeoplasmsMajor topic
CyclophosphamideMajor topic
Administration, Oral
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Doxorubicin
Female
Fluorouracil
Half-Life
Humans
Infusions, Intravenous
Obesity
Prednisone
Random Allocation

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1389529Clinical pharmacokinetics of cyclophosphamide.Clin Pharmacokinet1979https://conductscience.org/library/papers/389529PubMed
2109196Variable oral absorption of hexamethylmelamine in man.Cancer Treat Rep1978https://conductscience.org/library/papers/109196PubMed
37246555Estimating creatinine clearance in morbidity obese patients.Am J Hosp Pharm1981https://conductscience.org/library/papers/7246555PubMed
4385262Obesity.Dis Mon1979https://conductscience.org/library/papers/385262PubMed
57250178Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7250178PubMed
6630791Theophylline disposition in obesity.Clin Pharmacol Ther1978https://conductscience.org/library/papers/630791PubMed
76133901Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.J Lab Clin Med1983https://conductscience.org/library/papers/6133901PubMed
87459891PLasma half-life and urinary excretion of cyclophosphamide in children.Cancer Treat Rep1980https://conductscience.org/library/papers/7459891PubMed
94052122Ibuprofen disposition in obese individuals.Arthritis Rheum1985https://conductscience.org/library/papers/4052122PubMed
107282520Digoxin disposition in obesity: clinical pharmacokinetic investigation.Am Heart J1981https://conductscience.org/library/papers/7282520PubMed
116661365Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6661365PubMed
127083187Obesity, androgens, estrogens, and cancer risk.Cancer Res1982https://conductscience.org/library/papers/7083187PubMed
137448321Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.Biomedicine1980https://conductscience.org/library/papers/7448321PubMed
14507094Fatty liver hepatitis and cirrhosis in obese patients.Am J Med1979https://conductscience.org/library/papers/507094PubMed
156705134Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokinetic study.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6705134PubMed
166802647Influence of ascites on the pharmacokinetics of hexamethylmelamine and N-demethylated metabolites in ovarian cancer patients.Eur J Cancer Clin Oncol1981https://conductscience.org/library/papers/6802647PubMed
171003329
Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.
J Pharmacokinet Biopharm1976https://conductscience.org/library/papers/1003329PubMed
184688880Clinical pharmacology of cyclophosphamide.Cancer Res1973https://conductscience.org/library/papers/4688880PubMed
196862762Lean body mass in obesity.Int J Obes1983https://conductscience.org/library/papers/6862762PubMed
207039924Pharmacokinetics of drugs in obesity.Clin Pharmacokinet1982https://conductscience.org/library/papers/7039924PubMed

See all 37 referencesDownload CSV of references

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.

PMIDTitleJournalYearIn PapersSource
42678654Characterizing Tumor Cell Movement in Partial Differential Equation Models of Triple-Negative Breast Cancer Receiving Neoadjuvant Therapy.Ann Biomed Eng2026https://conductscience.org/library/papers/42678654PubMed
41298623Predicting the response of triple negative breast cancer to neoadjuvant systemic therapy via biology-based modeling and habitat analysis.Sci Rep2025https://conductscience.org/library/papers/41298623PubMed
41278162Predicting chemotherapy-induced myelosuppression in colorectal cancer: An interpretable, machine learning-based nomogram.World J Gastroenterol2025https://conductscience.org/library/papers/41278162PubMed
40410237Personalizing neoadjuvant chemotherapy regimens for triple-negative breast cancer using a biology-based digital twin.NPJ Syst Biol Appl2025https://conductscience.org/library/papers/40410237PubMed
39895779Risk Prediction of Myelosuppression Following First-line Chemotherapy in Colorectal Cancer.J Cancer2025https://conductscience.org/library/papers/39895779PubMed
37450841Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer.Cancer Epidemiol Biomarkers Prev2023https://conductscience.org/library/papers/37450841PubMed
36726585Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors.Front Pharmacol2023https://conductscience.org/library/papers/36726585PubMed
35946096Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.Curr Med Chem2023https://conductscience.org/library/papers/35946096PubMed
34725944Inter-ethnic differences in pharmacokinetics-is there more that unites than divides?Pharmacol Res Perspect2021https://conductscience.org/library/papers/34725944PubMed
34663641Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.J Immunother Cancer2021https://conductscience.org/library/papers/34663641PubMed
33239688Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer.Sci Rep2020https://conductscience.org/library/papers/33239688PubMed
33141242The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies.Eur J Nutr2021https://conductscience.org/library/papers/33141242PubMed
32390827Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients.Front Pharmacol2020https://conductscience.org/library/papers/32390827PubMed
29024537Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.Cancer Med2017https://conductscience.org/library/papers/29024537PubMed
26497907Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant2016https://conductscience.org/library/papers/26497907PubMed
26485568Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.PLoS One2015https://conductscience.org/library/papers/26485568PubMed
26180516Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.Cancer Cell Int2015https://conductscience.org/library/papers/26180516PubMed
26177092
Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.
PLoS One2015https://conductscience.org/library/papers/26177092PubMed
25483677Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: an exploratory study.Hum Vaccin Immunother2014https://conductscience.org/library/papers/25483677PubMed
25111511Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.Bone Marrow Transplant2014https://conductscience.org/library/papers/25111511PubMed

See all 47 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3315280

GET https://conductscience.org/api/papers/v1/3315280/references?page=2